18 January 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics examines the role of transient elastography and plasma cytokeratin-18 fragments for non-invasive assessment of NAFLD.
Non-alcoholic fatty liver disease (NAFLD) affects 15–40% of the general population. Some patients
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors